These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23891360)

  • 1. Ingestion of lanthanum carbonate tablets.
    Moazzam AA; Boongird S
    Am J Kidney Dis; 2013 Oct; 62(4):844. PubMed ID: 23891360
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lanthanum carbonate in clinical practice].
    Torregrosa Prats V
    Nefrologia; 2008; 28 Suppl 5():11-4. PubMed ID: 18847414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of oral powder compared with chewable tablets for lanthanum carbonate administration in hemodialysis patients.
    Sakurada T; Oishi D; Shibagaki Y; Yasuda T; Kimura K
    Hemodial Int; 2013 Oct; 17 Suppl 1():S2-6. PubMed ID: 24134326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Questionnaire survey and serum phosphorus levels in maintenance hemodialysis patients switching lanthanum carbonate formulation from chewable tablets to granules.
    Mukai I; Yoshizawa T; Kumagai J; Takahashi N; Tsuchiya S
    Ther Apher Dial; 2014 Jun; 18 Suppl 1():28-33. PubMed ID: 24953764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is granular formulation of lanthanum carbonate more effective than chewable tablets?
    Okamoto H; Haruhara K; Kamejima S; Mafune H; Manabe M; Kanzaki G; Mashiko H; Yokoo T
    Ther Apher Dial; 2014 Jun; 18 Suppl 1():23-7. PubMed ID: 24953763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of change in the formulation of lanthanum carbonate on laboratory parameters.
    Takita T; Furuhashi M; Fujimoto T; Suzuki H; Harada M; Maruyama S; Tamiya R; Kamiya E; Okamoto M; Tukada A; Furuhashi M; Kato A
    Ther Apher Dial; 2014 Jun; 18 Suppl 1():18-22. PubMed ID: 24953762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecalith formation and colonic perforation after lanthanum carbonate granules administration.
    Kurita N; Uchihara H
    Am J Kidney Dis; 2014 May; 63(5):861-2. PubMed ID: 24602779
    [No Abstract]   [Full Text] [Related]  

  • 8. Radio-opaque fecal impaction and pseudo-occlusion in a dialyzed patient taking lanthanum carbonate.
    Muller C; Muller S; Sissoko A; Klein A; Faller B; Chantrel F
    Hemodial Int; 2012 Oct; 16(4):556-8. PubMed ID: 22118504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysis.
    Finn WF; Joy MS;
    Curr Med Res Opin; 2005 May; 21(5):657-64. PubMed ID: 15969865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is lanthanum carbonate a safe drug?].
    Kazama JJ
    Clin Calcium; 2009 Feb; 19(2):224-8. PubMed ID: 19182363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of pharmacodynamic equivalence and tolerability of lanthanum carbonate oral powder and tablet formulations: a single-center, randomized, open-label, 2-period crossover study in healthy subjects.
    Pierce D; Hossack S; Robinson A; Zhang P; Martin P
    Clin Ther; 2012 Jun; 34(6):1290-1300.e2. PubMed ID: 22657252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dietary phosphate absorption after single doses of lanthanum carbonate and sevelamer carbonate in healthy volunteers: a balance study.
    Martin P; Wang P; Robinson A; Poole L; Dragone J; Smyth M; Pratt R
    Am J Kidney Dis; 2011 May; 57(5):700-6. PubMed ID: 21354682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute abdominal pain in a 70-year-old patient on hemodialysis].
    Kurz B; Müller GA
    Dtsch Med Wochenschr; 2009 Aug; 134(34-35):1677-8. PubMed ID: 19707963
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative evaluation of the in vitro efficacy of lanthanum carbonate chewable tablets.
    Yang Y; Bykadi S; Carlin AS; Shah RB; Yu LX; Khan MA
    J Pharm Sci; 2013 Apr; 102(4):1370-81. PubMed ID: 23334989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiographic disappearance of lanthanum].
    Pastori G
    G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of lanthanum carbonate ingestion thought to be phlebosclerotic colitis on CT imaging and abdominal radiograph.
    Harris K; Balcam S
    Radiography (Lond); 2017 Feb; 23(1):e23-e26. PubMed ID: 28290356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of lanthanum carbonate in German patients on dialysis.
    Dellanna F; Reichel H; Seibt F
    Clin Nephrol; 2012 Nov; 78(5):382-90. PubMed ID: 22948119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of continuous oral administration of lanthanum carbonate over 24 months.
    Ishizu T; Hong Z; Matsunaga T; Kaneko Y; Taru Y
    Ther Apher Dial; 2013 Apr; 17 Suppl 1():22-8. PubMed ID: 23586509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of calcium carbonate combined with calcitonin on hypercalcemia in hemodialysis patients.
    Wei Y; Kong XL; Li WB; Wang ZS
    Ther Apher Dial; 2014 Dec; 18(6):618-22. PubMed ID: 24674384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive function in Stage 5 chronic kidney disease patients on hemodialysis: no adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy.
    Altmann P; Barnett ME; Finn WF;
    Kidney Int; 2007 Feb; 71(3):252-9. PubMed ID: 17035945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.